ONCOLOGY/HEMATOLOGY
Adverse effects of AIs include cardiovascular dysfunction such as hypertension, vasodilation, edema, and chest pain.
ABSTRACT: Multiple myeloma accounts for approximately 1% of new cancer diagnoses in the United States each year.
ABSTRACT: Skin, the largest organ in the human body, has several functions, including protection from mechanical, thermal, and environmental impact.
Between 1975 and 2004 the number of new cases of melanoma rose, and it is estimated that 60,000 new cases occurred in 2007.
Iris BioTechnologies focuses on diagnostic therapy for individual patients based on their genomic profile.
ABSTRACT: Tumor lysis syndrome (TLS), an oncologic emergency, results when cancer cells are rapidly lysed after chemotherapy or other treatments.
ABSTRACT: The frequency of bone cancer is very rare, with only 400 to 700 new cases diagnosed annually.
ABSTRACT: Despite advancements in chemotherapy treatments, dermatologic complications continue to be associated with chemotherapeutic agents.
Phytoestrogens are trace biochemicals produced by plants that act like estrogens in animal cells and bodies.
The post-test exam and post-activity evaluation form are available at www.
Key Myeloma Mechanism Discovered In a discovery that might lead to a greater understanding of how multiple myeloma starts and how to best treat the disease, researchers from the National Cancer Institute (NCI) have identified changes to molecules in cancer cells that activate the NF-kappaB signaling pathway, which has an important role in cancer cell growth and survival.
ABSTRACT: In the United States, breast cancer and prostate cancer are the most common types of cancer diagnosed in women and men, respectively.
ABSTRACT: Non–small cell lung cancer (NSCLC) continues to be the leading cause of cancer death in the United States, and treatment for patients with advanced NSCLC remains an important, clinically complex challenge.
Genes May Have Role in Colorectal and Prostate Cancers Several studies suggest there may be a common genetic link to the development of colorectal and prostate cancers.
ABSTRACT: Chronic myelogenous leukemia (CML) is a hematologic malignancy associated with chromosomal abnormalities, including the Philadelphia chromosome (Ph).
ABSTRACT: Therapeutic cancer vaccines differ from traditional vaccines in that they are only given to patients who already have cancer, with the goal of decreasing the spread of the disease and prolonging survival.
ABSTRACT: In the United States, it is estimated that the frequency of venous thromboembolism (VTE) among cancer patients is approximately 1 in 200.
A South African study published in Lancet found that HIV-positive mothers who exclusively breast-fed their babies could likely cut HIV transmission in half.
New Drug to Treat Advanced Breast Cancer The FDA has approved lapatinib (Tykerb, GlaxoSmithKline), a new molecular entity to be used in combination with capectabine (Xeloda, Roche Laboratories), for patients with advanced, metastatic breast cancer that is HER2 positive.
Erythropoiesis, or the production of erythrocytes (i.
Skin cancer occurrence in organ transplant recipients (OTRs) is a rising phenomenon.
Prostate cancer is the most common solid tumor affecting men in the United States.
Thromboembolism is one of the leading causes of morbidity and mortality in the United States.
Blood clotting is a very complicated process.
Circumcision Reduces HIV Transmission Two studies in the Lancet bring the number of studies establishing a strong link between circumcision and a reduction in the risk of HIV transmission to three.
Number of New Cancer Patients Expected to Double The number of new cancer patients is expected to more than double in the United States over the next half-century from 1.
Breast Cancer Patients May Benefit from Second Opinion
ABSTRACT: Emesis as an adverse event of antineoplastic therapy can be troublesome for many oncology patients.
In the United States, kidney cancer (renal cell carcinoma) is estimated to be the seventh most common cancerous condition diagnosed in men and the 13th most common in women, accounting for 2.7% of all malignant conditions.
